|
|
|
|
Antiviral Activity, Safety, and Pharmacokinetics of GS-1720, a Novel Weekly Oral INSTI
|
|
|
CROI 2024 March 3-6 Denver
Carl J. Fichtenbaum*1, Mezgebe Berhe2, Jose Bordon3, Jacob Lalezari4, Godson Oguchi5, Gary Sinclair6, Furong Wang7, Brie Falkard7, Haeyoung Zhang7, Ana Z. Gonzalez7, Eva Mortensen7, Jared Baeten7, Moti Ramgopal8
|
|
|
|
|
|
|